Ovarian Cancer IMPACT Act
The source supplies the latest action, but no lifecycle stage.
Latest action (24 Sep 2026): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
What this bill does
This bill, S. 5554, titled "A bill to modernize and strengthen Federal efforts to improve ovarian cancer awareness, hereditary cancer risk assessment, access to genetic counseling and testing, and access to specialty care, and for other purposes," was introduced by Senator Elissa Slotkin of Michigan.
The bill aims to enhance federal programs focused on ovarian cancer. Specifically, it intends to improve public awareness of the disease, strengthen how hereditary cancer risks are assessed, and increase access to genetic counseling and testing. It also seeks to improve access to specialized medical care for affected individuals. The phrase "and for other purposes" suggests there may be additional provisions not detailed in the title.
The bill is currently in the early stages of the legislative process, having just been introduced in the 119th Congress. As the full text of the bill has not yet been published, its specific details and mechanisms for achieving these goals are not publicly available. After introduction, bills typically undergo committee review and potentially further debate and votes in the Senate and House of Representatives.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Timeline
24 Sep 2026
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Common questions
- What does S. 5554 do?
- This bill, S. 5554, titled "A bill to modernize and strengthen Federal efforts to improve ovarian cancer awareness, hereditary cancer risk assessment, access to genetic counseling and testing, and access to specialty care, and for other purposes," was introduced by Senator Elissa Slotkin of Michigan. The bill aims to enhance federal programs focused on ovarian cancer. Specifically, it intends to improve public awareness of the disease, strengthen how hereditary cancer risks are assessed, and increase access to genetic counseling and testing. It also seeks to improve access to specialized medical care for affected individuals. The phrase "and for other purposes" suggests there may be additional provisions not detailed in the title. The bill is currently in the early stages of the legislative process, having just been introduced in the 119th Congress. As the full text of the bill has not yet been published, its specific details and mechanisms for achieving these goals are not publicly available. After introduction, bills typically undergo committee review and potentially further debate and votes in the Senate and House of Representatives.
- Has S. 5554 become law?
- The source does not supply a confirmed lifecycle stage for S. 5554. Check the latest action and official source below.
- Who sponsored S. 5554?
- S. 5554 was sponsored by Sen. Slotkin, Elissa [D-MI] (D-MI), with 1 cosponsor.
- What's the latest action on S. 5554?
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (24 Sep 2026).
Related bills in Health
Choices for Increased Mobility Act of 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
340B Rebate Model Delay Act
Lower Premiums, Faster Payments Act
More bills from Sen. Slotkin, Elissa [D-MI]
A resolution supporting the designation of September 2026 as "National Ovarian Cancer Awareness Month".
A bill to require the Secretary of the Army to submit a report on efforts to support the production, testing, and sustainment of autonomous maneuver systems, components for such systems, and low-cost interceptors.
Military Leadership Removal Transparency Act of 2026
A bill to require a report on the advisability and feasibility of establishing a Drone Center of Excellence within the Army National Guard.
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.